Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma.
Cancer Cell Int. 2021 Sep 28;21(1):518. doi: 10.1186/s12935-021-02217-y.
Cancer Cell Int. 2021.
PMID: 34583688
Free PMC article.
Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma.
Wu X, Han R, Zhong Y, Weng N, Zhang A.
Wu X, et al.
Cancer Cell Int. 2021 Jul 7;21(1):356. doi: 10.1186/s12935-021-02072-x.
Cancer Cell Int. 2021.
PMID: 34233686
Free PMC article.
Item in Clipboard
Cite
Cite